Speaker illustration

Assistant Professor Mohammad Kermani-Alghoraishi

Interventional Cardiology Research Center, Isfahan (Iran (Islamic Republic of))

Member of:

EAPCI

Does allopurinol improve inflammatory biomarkers and post-revascularization coronary blood flow in Non-STEMI patients?

Event: ESC Preventive Cardiology 2022

Topic: Revascularisation

Session: ePosters

Thumbnail

Allopurinol pretreatment effects on coronary blood flow and revascularization outcomes in acute STEMI patients underwent emergency percutaneous coronary intervention

Event: ESC Acute CardioVascular Care 2022

Topic: Revascularisation

Session: e-Posters session

Thumbnail

This platform is supported by

logo Novo Nordisk